Skip to main content
Caplight Logo









BioPhoundry

BioPhoundry

Private
Chapel Hill, North CarolinaHealthcare & Life Scienceshttps://biophoundry.com/

Last Round

Seed

Jan 29, 2025

Total Funding Raised

$1.17M

Company Overview

BioPhoundry is a biotechnology company that develops a proprietary platform for automated, high-throughput phage engineering to create precision antibiotics for antimicrobial-resistant infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

bacteriophagephage therapysynthetic biologycell-free synthesisantimicrobial resistanceAMRbio-manufacturingdrug discoveryprecision medicinephage engineeringbio-foundryprotein designantibiotic alternativesbiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioPhoundry Comparables

Compare BioPhoundry with similar companies based on industry and business-model similarity.

BioPhoundry comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tolka AI Therapeutics
79%
Cytophage Technologies
77%
Locus Biosciences
76%

BioPhoundry Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 29, 2025

Key People

Founding team and executive leadership

Rani Brooks

Co-Founder & CEO

Founding Team

BioPhoundry Investors

Notable investors and investment history

BioPhoundry investors
InvestorRounds
The Creator FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 6, 2025

    Grew 133% QoQ, from 3 to 7 employees.

  • May 9, 2025

    Grew 100% QoQ from 3 to 6 employees.

BioPhoundry Filings

Explore SEC and related filing metadata, where available.

BioPhoundry filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioPhoundry's valuation, stock price, and market status.

Is BioPhoundry a public or private company?

BioPhoundry is a private company.

What is the current stock price of BioPhoundry?

BioPhoundry is a private company with no public stock price. Caplight tracks BioPhoundry's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is BioPhoundry worth (valuation)?

Valuation information for BioPhoundry is not publicly available.

Can I buy BioPhoundry stock?

BioPhoundry shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioPhoundry's last funding round?

BioPhoundry's most recent funding round was Seed on January 29, 2025.

Who are the main investors in BioPhoundry?

Key investors in BioPhoundry include The Creator Fund.

Will BioPhoundry IPO soon?

No public IPO plans have been announced for BioPhoundry.

How can I track BioPhoundry secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioPhoundry's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChapel Hill, North Carolina
Employee Range6
Year Founded2023
Last FundingJan 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?